|
1
|
Yazawa K, Fujimori M, Nakamura T, Sasaki
T, Amano J, Kano Y and Taniguchi S: Bifidobacterium longum as a
delivery system for gene therapy of chemically induced rat mammary
tumors. Breast Cancer Res Treat. 66:165–170. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fujimori M: Anaerobic bacteria as a gene
delivery system for breast cancer therapy. Nihon Rinsho.
66:1211–1218. 2008.(In Japanese). PubMed/NCBI
|
|
3
|
Liu SC, Ahn GO, Kioi M, Dorie MJ,
Patterson AV and Brown JM: Optimized clostridium-directed enzyme
prodrug therapy improves the antitumor activity of the novel DNA
cross-linking agent PR-104. Cancer Res. 68:7995–8003. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhao M, Yang M, Ma H, Li X, Tan X, Li S,
Yang Z and Hoffman RM: Targeted therapy with a Salmonella
typhimurium leucine-arginine auxotroph cures orthotopic human
breast tumors in nude mice. Cancer Res. 66:7647–7652. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Low KB, Ittensohn M, Le T, Platt J, Sodi
S, Amoss M, Ash O, Carmichael E, Chakraborty A, Fischer J, et al:
Lipid A mutant Salmonella with suppressed virulence and TNFalpha
induction retain tumor-targeting in vivo. Nat Biotechnol. 17:37–41.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Felgner S, Kocijancic D, Frahm M, Curtiss
R III, Erhardt M and Weiss S: Optimizing salmonella enterica
serovar typhimurium for bacteria-mediated tumor therapy. Gut
microbes. 7:171–177. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Frahm M, Felgner S, Kocijancic D, Rohde M,
Hensel M, Curtiss R III, Erhardt M and Weiss S: Efficiency of
conditionally attenuated Salmonella enterica serovar Typhimurium in
bacterium-mediated tumor therapy. mBio. 6:pii: e00254–15. 2015.
View Article : Google Scholar
|
|
8
|
Yu B, Yang M, Shi L, Yao Y, Jiang Q, Li X,
Tang LH, Zheng BJ, Yuen KY, Smith DK, et al: Explicit hypoxia
targeting with tumor suppression by creating an ‘obligate’
anaerobic Salmonella Typhimurium strain. Sci Rep. 2:4362012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tang X: Tumor-associated macrophages as
potential diagnostic and prognostic biomarkers in breast cancer.
Cancer Lett. 332:3–10. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Luo Y, Zhou H, Krueger J, Kaplan C, Lee
SH, Dolman C, Markowitz D, Wu W, Liu C, Reisfeld RA and Xiang R:
Targeting tumor-associated macrophages as a novel strategy against
breast cancer. J Clin Invest. 116:2132–2141. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Leek RD, Lewis CE, Whitehouse R, Greenall
M, Clarke J and Harris AL: Association of macrophage infiltration
with angiogenesis and prognosis in invasive breast carcinoma.
Cancer Res. 56:4625–4629. 1996.PubMed/NCBI
|
|
12
|
DeNardo DG, Barreto JB, Andreu P, Vasquez
L, Tawfik D, Kolhatkar N and Coussens LM: CD4(+) T cells regulate
pulmonary metastasis of mammary carcinomas by enhancing protumor
properties of macrophages. Cancer cell. 16:91–102. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang C, Gao L, Cai Y, Liu H, Gao D, Lai
J, Jia B, Wang F and Liu Z: Inhibition of tumor growth and
metastasis by photoimmunotherapy targeting tumor-associated
macrophage in a sorafenib-resistant tumor model. Biomaterials.
84:1–12. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Khabbazi S, Goumon Y and Parat MO:
Morphine modulates interleukin-4- or breast cancer cell-induced
pro-metastatic activation of macrophages. Sci Rep. 5:113892015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Su S, Liu Q, Chen J, Chen J, Chen F, He C,
Huang D, Wu W, Lin L, Huang W, et al: A positive feedback loop
between mesenchymal-like cancer cells and macrophages is essential
to breast cancer metastasis. Cancer cell. 25:605–620. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dangaj D, Abbott KL, Mookerjee A, Zhao A,
Kirby PS, Sandaltzopoulos R, Powell DJ Jr, Lamazière A, Siegel DL,
Wolf C and Scholler N: Mannose receptor (MR) engagement by
mesothelin GPI anchor polarizes tumor-associated macrophages and is
blocked by anti-MR human recombinant antibody. PLoS One.
6:e283862011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kuang DM, Wu Y, Chen N, Cheng J, Zhuang SM
and Zheng L: Tumor-derived hyaluronan induces formation of
immunosuppressive macrophages through transient early activation of
monocytes. Blood. 110:587–595. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang M, Chen J, Su F, Yu B, Su F, Lin L,
Liu Y, Huang JD and Song E: Microvesicles secreted by macrophages
shuttle invasion-potentiating microRNAs into breast cancer cells.
Mol cancer. 10:1172011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen J, Yao Y, Gong C, Yu F, Su S, Chen J,
Liu B, Deng H, Wang F, Lin L, et al: CCL18 from tumor-associated
macrophages promotes breast cancer metastasis via PITPNM3. Cancer
Cell. 19:541–555. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Castoldi A, Naffah de Souza C, Câmara NO
and Moraes-Vieira PM: The macrophage switch in obesity development.
Front Immunol. 6:6372016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hamaidia M, Staumont B, Duysinx B, Louis R
and Willems L: Improvement of malignant pleural mesothelioma
immunotherapy by epigenetic modulators. Curr Top Med Chem.
16:777–787. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Murray PJ and Wynn TA: Protective and
pathogenic functions of macrophage subsets. Nat Rev Immunol.
11:723–737. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hambleton J, Weinstein SL, Lem L and
DeFranco AL: Activation of c-Jun N-terminal kinase in bacterial
lipopolysaccharide-stimulated macrophages. Proc Natl Acad Sci USA.
93:pp. 2774–2778. 1996; View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chimal-Ramírez GK, Espinoza-Sánchez NA,
Chávez-Sánchez L, Arriaga-Pizano L and Fuentes-Pananá EM: Monocyte
differentiation towards protumor activity does not correlate with
M1 or M2 phenotypes. J Immunol Res. 2016:60314862016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guo H, Liu Y, Gu J, Wang Y, Liu L, Zhang P
and Li Y: Endostatin inhibits the growth and migration of 4T1 mouse
breast cancer cells by skewing macrophage polarity toward the M1
phenotype. Cancer Immunol Immunother. 65:677–688. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cameron DJ and Churchill WH: Cytotoxicity
of human macrophages for tumor cells: Enhancement by bacterial
lipopolysaccharides (LPS). J Immunol. 124:708–712. 1980.PubMed/NCBI
|
|
27
|
Sinha P, Clements VK, Miller S and
Ostrand-Rosenberg S: Tumor immunity: A balancing act between T cell
activation, macrophage activation and tumor-induced immune
suppression. Cancer Immunol Immunother. 54:1137–1142. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mills CD, Lenz LL and Harris RA: A
breakthrough: Macrophage-directed cancer immunotherapy. Cancer Res.
76:513–516. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mitra R, Singh S and Khar A: Antitumour
immune responses. Expert Rev Mol Med. 5:1–19. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mantovani A, Sozzani S, Locati M, Allavena
P and Sica A: Macrophage polarization: Tumor-associated macrophages
as a paradigm for polarized M2 mononuclear phagocytes. Trends
Immunol. 23:549–555. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wahl LM and Kleinman HK: Tumor-associated
macrophages as targets for cancer therapy. J Natl Cancer Inst.
90:1583–1584. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ueno T, Toi M, Saji H, Muta M, Bando H,
Kuroi K, Koike M, Inadera H and Matsushima K: Significance of
macrophage chemoattractant protein-1 in macrophage recruitment,
angiogenesis, and survival in human breast cancer. Clin Cancer Res.
6:3282–3289. 2000.PubMed/NCBI
|
|
33
|
Leek RD and Harris AL: Tumor-associated
macrophages in breast cancer. J Mammary Gland Biol Neoplasia.
7:177–189. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Valković T, Dobrila F, Melato M, Sasso F,
Rizzardi C and Jonjić N: Correlation between vascular endothelial
growth factor, angiogenesis, and tumor-associated macrophages in
invasive ductal breast carcinoma. Virchows Arch. 440:583–588. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Deng R, Wang SM, Yin T, Ye TH, Shen GB, Li
L, Zhao JY, Sang YX, Duan XG and Wei YQ: Inhibition of tumor growth
and alteration of associated macrophage cell type by an HO-1
inhibitor in breast carcinoma-bearing mice. Oncol Res. 20:473–482.
2013. View Article : Google Scholar : PubMed/NCBI
|
